Physician profile
Richard E Pearl
NPI 1780831404
$21,907.88
in general payments reported to CMS, 2019-2025
28 companies · $2,168 in 2025
The $2,168 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $641 · 2021: $910 · 2022: $5,728 · 2023: $2,820 · 2024: $8,195 · 2025: $2,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,776 · Food and Beverage: $4,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,775.54 |
| Food and Beverage | $4,407.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $6,313.57 | 2022-2024 | Djo Surgical |
| Smith+Nephew, INC. | $4,674.82 | 2019-2025 | Real Intelligence, Journey, Journey II |
| Linkbio Corp | $2,947.54 | 2023-2024 | |
| Medacta USA, INC. | $2,814.23 | 2023-2024 | Amistem, Gmk Sphere |
| Seapearl East, INC | $1,263.22 | 2020-2023 | |
| Abbott Laboratories | $519.17 | 2023-2024 | Proclaim |
| Royal Biologics, INC. | $389.80 | 2021-2022 | |
| Omnilife Science, INC | $349.08 | 2025 | |
| Total Joint Orthopedics, INC. | $348.23 | 2019 | |
| Nevro Corp. | $284.22 | 2019 | |
| Onkos Surgical, INC. | $251.47 | 2019-2022 | |
| Stryker Corporation | $236.80 | 2020-2023 | Mako |
| Bone Support INC. | $208.52 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Mimedx Group, INC. | $200.14 | 2025 | |
| Horizon Therapeutics Plc | $158.07 | 2020-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $125.00 | 2020 | |
| Heron Therapeutics, INC. | $115.02 | 2022-2023 | Zynrelef |
| 4web, INC. | $114.78 | 2025 | Spine Truss System |
| Uoc USA INC | $110.65 | 2024 | U2, Conformity and U-Motion II |
| Ortho Development Corporation | $105.86 | 2024 | |
| Zimmer Biomet Holdings, INC. | $104.68 | 2024 | G7 |
| Gotham Surgical Solutions & Devices, INC. | $84.58 | 2022 | |
| Depuy Synthes Sales INC. | $40.66 | 2022 | |
| Curonix LLC | $34.07 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Intellijoint Surgical INC. | $31.78 | 2025 | Intellijoint Hip |
| Bioventus LLC | $28.44 | 2019 | |
| Linvatec Corporation | $28.31 | 2025 | Linvatec Arthroscopy |
| Axogen | $25.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Pearl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.